Serina Therapeutics, Inc. (SER)

Listed in the US · Manufacturing · Pharmaceutical preparations

$1.89

As of 29 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close $1.89 on 29 Oct 2026. The share price traded between $1.22 and $5.00 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close $1.89

Low $1.22High $5.00

Market cap$48Mlast close × shares
EBITDA marginn/myear to Dec 2025
Net marginn/myear to Dec 2025
Dividend yieldnonelast 12 months

Revenue is very small next to this company's costs or profit, so its margins here are extreme figures (beyond ±100%). They are what the reported numbers give, but they say little about how the business earns.

Price trend

Revenue and profit

RevenueNet profit$ million
-20-10010
YearDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue0.140.033.150.060.13
Net profit-8.68-10.465.27-11.14-19.18
EBITDA margin––-96.4%n/mn/m
Borrowings13.2018.12–––

$ million. Over three years, compounded: revenue grew 63.0% a year.

Recent filings

Questions about Serina Therapeutics, Inc.

What is Serina Therapeutics, Inc.'s market value?

Serina Therapeutics, Inc.'s market value is $48M as of 29 Oct 2026 close: the last close times the shares in issue.

Go further with SER

Free to start: test a trading idea on SER's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Pharmaceutical preparations), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out